Accomplishments
A case series of generalized lichenoid drug eruption due to anti-tubercular drugs: Treated with immunosuppressant’s while continuing anti-tubercular therapy
Category
Articles
Authors
Publisher
Wolters Kluwer - Medknow
Publishing Date
01-Jun-2022
volume
8
Issue
1
Pages
23-28
- Abstract
- PDF Full Text
The spectrum of tuberculosis-associated cutaneous adverse drug reactions (ADRs) is wide and includes Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and generalized lichenoid drug eruption (LDE). LDE constitutes less than 10% of the total incidence of anti-tubercular drug induced cutaneous ADRs. In any type of drug reaction there is a prompt need of withdrawal of suspected drugs and institution of aggressive treatment of ADRs with proper control of underlying primary disease. Herein, we present a case series of five cases of generalized LDE due to anti tubercular therapy (ATT), in whom cutaneous lesions were managed with oral immunosuppressants while continuing ATT.
Related Items
HARI PATHAVE. (2023).
Recalcitrant livedoid vasculopathy:A succesful treatment with oral rivaroxaban.
Indian Journal of Drugs in Dermatology,Volume 8(Issue 2): 89-93.
HARI PATHAVE. (2022).
Clinicomycological Study of Superficial Mycoses: A Changing Trend of Increasing Non-dermatophyte Mold Infection.
Journal of College of Medical Sciences-Nepal,18(1): 49-59.doi: 10.3126/jcmsn.v18i1.41141